Patents of Immunotec

Patent # 1,333,471 issued 1994/12/13 Canada

Effect of dietary whey protein (lactabumin) on the immune response to sheep red blood cells,
host resistance to bacterial infections, development of tumors and the process of aging.
Patent # 1338682 issued 1996/10/29 Canada
Biologic activity
Patent # 2,090,186 issued 1999/03/16 Canada
HIV treatment
Patent # 2,142,277 issued 2000/01/18 Canada
This invention relates to a method of treatment of patients having lesions resulting from
cancer cells and to an application as an anti-cancer composition of undenatured whey protein
concentrate.
Patent # 2,176,946 issued 2006/02/07 Canada
Method of production
Patent # 5,230,902 issued July 27, 1993 US
improving immune response
Patent # 5,290,571 issued Mar 1 1994 US
Biological active whey protein concentrate and method of production
Patent # 5,451,412 issued Sep 19,1998 US
Food supplement with applications and method of production
Patent # 5,456,924 issued Oct 10, 1995 US
HIV treatment
Patent # 5,888,552 issued Mar 30, 1999 US
This invention relates to a method of treatment of patients having lesions resulting from
cancer cells and to an application as an anti-cancer composition of undenatured whey protein
concentrate.
Patent # 5,846,939 issued Dec 8, 1998 US
PNT 200
Patent # 6,927,231 B2 issued Aug 9, 2005 US
use of Creatine for the amelioration of oxidate stress
(related to aging, cancer, neurodegeneative diseases)
Creatine is a component of Immunocal Platinum